CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells (Englisch)
Freier Zugriff
- Neue Suche nach: Natsagdorj, Ariunbold
- Neue Suche nach: Izumi, Kouji
- Neue Suche nach: Hiratsuka, Kaoru
- Neue Suche nach: Machioka, Kazuaki
- Neue Suche nach: Iwamoto, Hiroaki
- Neue Suche nach: Naito, Renato
- Neue Suche nach: Makino, Tomoyuki
- Neue Suche nach: Kadomoto, Suguru
- Neue Suche nach: Shigehara, Kazuyoshi
- Neue Suche nach: Kadono, Yoshifumi
- Neue Suche nach: Lin, Wen‐Jye
- Neue Suche nach: Maolake, Aerken
- Neue Suche nach: Mizokami, Atsushi
- Neue Suche nach: Natsagdorj, Ariunbold
- Neue Suche nach: Izumi, Kouji
- Neue Suche nach: Hiratsuka, Kaoru
- Neue Suche nach: Machioka, Kazuaki
- Neue Suche nach: Iwamoto, Hiroaki
- Neue Suche nach: Naito, Renato
- Neue Suche nach: Makino, Tomoyuki
- Neue Suche nach: Kadomoto, Suguru
- Neue Suche nach: Shigehara, Kazuyoshi
- Neue Suche nach: Kadono, Yoshifumi
- Neue Suche nach: Lin, Wen‐Jye
- Neue Suche nach: Maolake, Aerken
- Neue Suche nach: Mizokami, Atsushi
In:
Cancer Science
;
110
, 1
;
279-288
;
2019
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells
-
Beteiligte:Natsagdorj, Ariunbold ( Autor:in ) / Izumi, Kouji ( Autor:in ) / Hiratsuka, Kaoru ( Autor:in ) / Machioka, Kazuaki ( Autor:in ) / Iwamoto, Hiroaki ( Autor:in ) / Naito, Renato ( Autor:in ) / Makino, Tomoyuki ( Autor:in ) / Kadomoto, Suguru ( Autor:in ) / Shigehara, Kazuyoshi ( Autor:in ) / Kadono, Yoshifumi ( Autor:in )
-
Erschienen in:Cancer Science ; 110, 1 ; 279-288
-
Verlag:
-
Erscheinungsdatum:01.01.2019
-
Format / Umfang:10 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 110, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Issue Information| 2019
- 4
-
In this Issue| 2019
- 6
-
Next generation sequencing‐based gene panel tests for the management of solid tumorsNagahashi, Masayuki / Shimada, Yoshifumi / Ichikawa, Hiroshi / Kameyama, Hitoshi / Takabe, Kazuaki / Okuda, Shujiro / Wakai, Toshifumi et al. | 2019
- 16
-
Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapyIriguchi, Shoichi / Kaneko, Shin et al. | 2019
- 23
-
Novel application of metformin combined with targeted drugs on anticancer treatmentDeng, Jun / Peng, Mei / Wang, Zhiren / Zhou, Sichun / Xiao, Di / Deng, Jiating / Yang, Xue / Peng, Jingyuan / Yang, Xiaoping et al. | 2019
- 31
-
Combination immunotherapy with interleukin‐2 surface‐modified tumor cell vaccine and programmed death receptor‐1 blockade against renal cell carcinomaZhang, Xinji / Shi, Xiaojun / Li, Jinlong / Hu, Zhiming / Gao, Jimin / Wu, Shihao / Long, Zhaolin et al. | 2019
- 40
-
Development of a T‐cell receptor multimer with high avidity for detecting a naturally presented tumor‐associated antigen on osteosarcoma cellsWatanabe, Kazue / Tsukahara, Tomohide / Toji, Shingo / Saitoh, Shogo / Hirohashi, Yoshihiko / Nakatsugawa, Munehide / Kubo, Terufumi / Kanaseki, Takayuki / Kameshima, Hidekazu / Terui, Takeshi et al. | 2019
- 52
-
Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancerWatanabe, Satomi / Hayashi, Hidetoshi / Haratani, Koji / Shimizu, Shigeki / Tanizaki, Junko / Sakai, Kazuko / Kawakami, Hisato / Yonesaka, Kimio / Tsurutani, Junji / Togashi, Yosuke et al. | 2019
- 61
-
T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancerCui, Can / Tian, Xiuyun / Wu, Jianhui / Zhang, Chaoting / Tan, Qin / Guan, Xiaoya / Dong, Bin / Zhao, Min / Lu, Zheming / Hao, Chunyi et al. | 2019
- 72
-
Long noncoding RNA MAPKAPK5‐AS1 promotes colorectal cancer proliferation by partly silencing p21 expressionJi, Hao / Hui, Bingqing / Wang, Jirong / Zhu, Ya / Tang, Lingyu / Peng, Peng / Wang, Tianjun / Wang, Lijuan / Xu, Shufeng / Li, Juan et al. | 2019
- 86
-
Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial‐mesenchymal transition and 5‐fluorouracil resistanceLiu, ZhengYi / Chen, JinHuang / Yuan, WenZheng / Ruan, HaiLong / Shu, Yan / Ji, JinTong / Wu, Liang / Tang, Qiang / Zhou, ZiLi / Zhang, XuDan et al. | 2019
- 99
-
Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA‐223/fibroblast growth factor receptor 2 axisYang, Chen / Wu, Siqi / Wu, Xiaobo / Zhou, Xuejian / Jin, Shengming / Jiang, Haowen et al. | 2019
- 107
-
P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5Wang, Rui / Bao, Hong‐Bo / Du, Wen‐Zhong / Chen, Xiao‐Feng / Liu, Huai‐Lei / Han, Da‐Yong / Wang, Li‐Gang / Wu, Jia‐Ning / Wang, Chun‐Lei / Yang, Ming‐Chun et al. | 2019
- 118
-
Podocalyxin‐like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 proteinZhi, Qiaoming / Chen, Huo / Liu, Fei / Han, Ye / Wan, Daiwei / Xu, Zhihua / Kuang, Yuting / Zhou, Jin et al. | 2019
- 135
-
MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1Liu, Jiao / Shao, Yangguang / He, Yuxin / Ning, Ke / Cui, Xi / Liu, Furong / Wang, Zhenning / Li, Feng et al. | 2019
- 147
-
Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis modelHattori, Naoko / Niwa, Tohru / Ishida, Tatsuya / Kobayashi, Kyosuke / Imai, Toshio / Mori, Akiko / Kimura, Kana / Mori, Takeshi / Asami, Yukio / Ushijima, Toshikazu et al. | 2019
- 157
-
DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasisQu, Di / Cui, Feng / Lu, Dan / Yang, Yu / Xu, Yuqing et al. | 2019
- 166
-
Y‐box binding protein‐1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordomaLiang, Chen / Ma, Yunlong / Yong, Lei / Yang, Chenlong / Wang, Peng / Liu, Xiao / Zhu, Bin / Zhou, Hua / Liu, Xiaoguang / Liu, Zhongjun et al. | 2019
- 180
-
Establishment and characterization of CRISPR/Cas9‐mediated NF2−/− human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesotheliomaWahiduzzaman, Md / Karnan, Sivasundaram / Ota, Akinobu / Hanamura, Ichiro / Murakami, Hideki / Inoko, Akihito / Rahman, Md Lutfur / Hyodo, Toshinori / Konishi, Hiroyuki / Tsuzuki, Shinobu et al. | 2019
- 194
-
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myelomaNakagawa, Makoto / Fujita, Shuhei / Katsumoto, Takuo / Yamagata, Kazutsune / Ogawara, Yoko / Hattori, Ayuna / Kagiyama, Yuki / Honma, Daisuke / Araki, Kazushi / Inoue, Tatsuya et al. | 2019
- 209
-
Palbociclib enhances activin‐SMAD‐induced cytostasis in estrogen receptor‐positive breast cancerHarada, Mayumi / Morikawa, Masato / Ozawa, Takayuki / Kobayashi, Mai / Tamura, Yusuke / Takahashi, Kei / Tanabe, Masahiko / Tada, Keiichiro / Seto, Yasuyuki / Miyazono, Kohei et al. | 2019
- 221
-
Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cellsQu, Chao / Ma, Jingyun / Zhang, Yejun / Han, Chao / Huang, Liang / Shen, Liming / Li, Hongyan / Wang, Xiaobo / Liu, Jing / Zou, Wei et al. | 2019
- 235
-
Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl‐xL pathwayHara, Masaki / Takeba, Yuko / Iiri, Taroh / Ohta, Yuki / Ootaki, Masanori / Watanabe, Minoru / Watanabe, Daiki / Koizumi, Satoshi / Otsubo, Takehito / Matsumoto, Naoki et al. | 2019
- 245
-
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancerLee, Ahn R. / Gan, Yu / Xie, Ning / Ramnarine, Varune R. / Lovnicki, Jessica M. / Dong, Xuesen et al. | 2019
- 256
-
CD47 agonist peptide PKHB1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cellsUscanga‐Palomeque, Ashanti Concepción / Calvillo‐Rodríguez, Kenny Misael / Gómez‐Morales, Luis / Lardé, Eva / Denèfle, Thomas / Caballero‐Hernández, Diana / Merle‐Béral, Hélène / Susin, Santos A. / Karoyan, Philippe / Martínez‐Torres, Ana Carolina et al. | 2019
- 269
-
Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cellsSakamoto, Akihiko / Kunou, Shunsuke / Shimada, Kazuyuki / Tsunoda, Makoto / Aoki, Tomohiro / Iriyama, Chisako / Tomita, Akihiro / Nakamura, Shigeo / Hayakawa, Fumihiko / Kiyoi, Hitoshi et al. | 2019
- 279
-
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cellsNatsagdorj, Ariunbold / Izumi, Kouji / Hiratsuka, Kaoru / Machioka, Kazuaki / Iwamoto, Hiroaki / Naito, Renato / Makino, Tomoyuki / Kadomoto, Suguru / Shigehara, Kazuyoshi / Kadono, Yoshifumi et al. | 2019
- 289
-
Downregulation of long non‐coding RNA Opa interacting protein 5‐antisense RNA 1 inhibits breast cancer progression by targeting sex‐determining region Y‐box 2 by microRNA‐129‐5p upregulationZeng, Huijuan / Wang, Jingjie / Chen, Tao / Zhang, Kai / Chen, Jing / Wang, Lulu / Li, Hanjun / Tuluhong, Dilihumaer / Li, Jieshou / Wang, Shaohua et al. | 2019
- 303
-
Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation studyMakishima, Hirokazu / Yasuda, Shigeo / Isozaki, Yuka / Kasuya, Goro / Okada, Naomi / Miyazaki, Masaru / Mohamad, Osama / Matsufuji, Naruhiro / Yamada, Shigeru / Tsuji, Hiroshi et al. | 2019
- 310
-
PD‐L1 expression enhancement by infiltrating macrophage‐derived tumor necrosis factor‐α leads to poor pancreatic cancer prognosisTsukamoto, Masayo / Imai, Katsunori / Ishimoto, Takatsugu / Komohara, Yoshihiro / Yamashita, Yo‐ichi / Nakagawa, Shigeki / Umezaki, Naoki / Yamao, Takanobu / Kitano, Yuki / Miyata, Tatsunori et al. | 2019
- 321
-
Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for gliomaLiu, Yu‐Qing / Chai, Rui‐Chao / Wang, Yong‐Zhi / Wang, Zheng / Liu, Xing / Wu, Fan / Jiang, Tao et al. | 2019
- 334
-
Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblastsIshii, Norihiro / Araki, Kenichiro / Yokobori, Takehiko / Hagiwara, Kei / Gantumur, Dorgormaa / Yamanaka, Takahiro / Handa, Tadashi / Tsukagoshi, Mariko / Igarashi, Takamichi / Watanabe, Akira et al. | 2019
- 345
-
High‐throughput screening in colorectal cancer tissue‐originated spheroidsKondo, Jumpei / Ekawa, Tomoya / Endo, Hiroko / Yamazaki, Kanami / Tanaka, Norio / Kukita, Yoji / Okuyama, Hiroaki / Okami, Jiro / Imamura, Fumio / Ohue, Masayuki et al. | 2019
- 356
-
Simultaneous hyperthermia‐chemotherapy effect by arterial injection of Fe(Salen) for femur tumorUmemura, Masanari / Islam, Md. Rafikul / Fukumura, Hidenobu / Sato, Itaru / Kawabata, Yusuke / Matsuo, Kousuke / Nakakaji, Rina / Nagasako, Akane / Ohtake, Makoto / Takayuki, Fujita et al. | 2019
- 366
-
2′‐Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generationYoon, Yae Jin / Kim, Young‐Hwan / Lee, Yu‐Jin / Choi, Jiyeon / Kim, Cheol‐Hee / Han, Dong Cho / Kwon, Byoung‐Mog et al. | 2019
- 379
-
All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctionsShi, Guiling / Zheng, Xiaoli / Wu, Xiaojing / Wang, Siqi / Wang, Yijia / Xing, Fei et al. | 2019
- 389
-
20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastomaChen, Zheng / Wei, Xiangyu / Shen, Lin / Zhu, Hanshuo / Zheng, Xuesheng et al. | 2019
- 401
-
Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphomaHattori, Keiichiro / Sakata‐Yanagimoto, Mamiko / Kusakabe, Manabu / Nanmoku, Toru / Suehara, Yasuhito / Matsuoka, Ryota / Noguchi, Masayuki / Yokoyama, Yasuhisa / Kato, Takayasu / Kurita, Naoki et al. | 2019
- 408
-
Circulating miRNA panels for specific and early detection in bladder cancerUsuba, Wataru / Urabe, Fumihiko / Yamamoto, Yusuke / Matsuzaki, Juntaro / Sasaki, Hideo / Ichikawa, Makiko / Takizawa, Satoko / Aoki, Yoshiaki / Niida, Shumpei / Kato, Ken et al. | 2019
- 420
-
Involvement of dual‐strand of the miR‐144 duplex and their targets in the pathogenesis of lung squamous cell carcinomaUchida, Akifumi / Seki, Naohiko / Mizuno, Keiko / Misono, Shunsuke / Yamada, Yasutaka / Kikkawa, Naoko / Sanada, Hiroki / Kumamoto, Tomohiro / Suetsugu, Takayuki / Inoue, Hiromasa et al. | 2019
- 433
-
Tumor‐derived exosomal proteins as diagnostic biomarkers in non‐small cell lung cancerNiu, Limin / Song, Xingguo / Wang, Ning / Xue, Linlin / Song, Xianrang / Xie, Li et al. | 2019
- 443
-
Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomasTakata, Katsuyoshi / Saito, Ken / Maruyama, Satoshi / Miyata‐Takata, Tomoko / Iioka, Hidekazu / Okuda, Shujiro / Ling, Yiwei / Karube, Kennosuke / Miki, Yukari / Maeda, Yoshinobu et al. | 2019
- 458
-
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancerTian, Da‐Wei / Wu, Zhou‐Liang / Jiang, Li‐Ming / Gao, Jie / Wu, Chang‐Li / Hu, Hai‐Long et al. | 2019